Large-Scale Virtual Screening Against the MET Kinase Domain Identifies a New Putative Inhibitor Type

Large-Scale Virtual Screening Against the MET Kinase Domain Identifies a New Putative Inhibitor Type

By using an ensemble-docking strategy, we undertook a large-scale virtual screening campaign in order to identify new putative hits against the MET kinase target. Following a large molecular dynamics sampling of its conformational space, a set of 45 conformers of the kinase was retained as docking t...

Full description

Bibliographic Details
Main Authors:	Emmanuel Bresso, Alessandro Furlan, Philippe Noel, Vincent Leroux, Flavio Maina, Rosanna Dono, Bernard Maigret
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Molecules
Subjects:	virtual screening ensemble-docking structure-based drug design cross-docking validation induced fit conformational selection met kinase
Online Access:	https://www.mdpi.com/1420-3049/25/4/938

Similar Items

KRDS: a web server for evaluating drug resistance mutations in kinases by molecular docking
by: Aeri Lee, et al.
Published: (2018-04-01)

Studying the Binding Modes of Novel 2-Aminopyridine Derivatives as Effective and Selective c-Met Kinase Type 1 Inhibitors Using Molecular Modeling Approaches
by: Qianwen Ye, et al.
Published: (2020-12-01)

Design, synthesis, and biological evaluation of thiazole/thiadiazole carboxamide scaffold-based derivatives as potential c-Met kinase inhibitors for cancer treatment
by: Xiang Nan, et al.
Published: (2023-12-01)

Consensus combining outcomes of multiple ensemble dockings: examples using dDAT crystalized complexes
by: Fabiani Triches, et al.
Published: (2022-01-01)

Targeting the C-Terminal Domain Small Phosphatase 1
by: Harikrishna Reddy Rallabandi, et al.
Published: (2020-05-01)

The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
by: Tejas Patil, MD, et al.
Published: (2024-02-01)

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
by: Yu Yao, et al.
Published: (2023-01-01)

Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
by: Ming Zeng, et al.
Published: (2024-03-01)

Suitable Docking Protocol for the Design of Novel Coumarin Derivatives with Selective MAO-B Effects
by: Emilio Viktorov Mateev, et al.
Published: (2021-06-01)

Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein–Protein Binding
by: Ádám L. Póti, et al.
Published: (2023-10-01)

Applying atomistic neural networks to bias conformer ensembles towards bioactive-like conformations
by: Benoit Baillif, et al.
Published: (2023-12-01)

Molecular Docking, PASS Prediction, Pharmacokinetic and Toxicity Studies of Focal Adhesion Kinase Inhibitors
by: Sahaya Nadar, et al.
Published: (2022-11-01)

Using parallelized incremental meta-docking can solve the conformational sampling issue when docking large ligands to proteins
by: Didier Devaurs, et al.
Published: (2019-09-01)

Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular
by: Khaoula Mkhayar, et al.
Published: (2022-11-01)

S4MPLE—Sampler for Multiple Protein-Ligand Entities: Methodology and Rigid-Site Docking Benchmarking
by: Laurent Hoffer, et al.
Published: (2015-05-01)

Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases
by: Baby B, et al.
Published: (2016-09-01)

STUDY IN SILICO OF THIOUREA-DERIVED COMPOUNDS AS TYROSINE KINASE RECEPTOR INHIBITORS
by: Budi Mulyati, et al.
Published: (2022-12-01)

Characterization of Aspartate Kinase from Corynebacterium pekinense and the Critical Site of Arg169
by: Weihong Min, et al.
Published: (2015-11-01)

Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
by: Karen Koo, et al.
Published: (2023-03-01)

Theoretical Investigations on Interactions of Arylsulphonyl Indazole Derivatives as Potential Ligands of VEGFR2 Kinase
by: Kornelia Czaja, et al.
Published: (2020-07-01)

Design, Synthesis, and Evaluation of New Mesenchymal–Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers
by: Han Yao, et al.
Published: (2022-08-01)

A MET-PTPRK kinase-phosphatase rheostat controls ZNRF3 and Wnt signaling
by: Minseong Kim, et al.
Published: (2021-09-01)

Molecular Docking Evaluation of (E)-5-arylidene-2-thioxothiazolidin-4-one Derivatives as Selective Bacterial Adenylate Kinase Inhibitors
by: Mihaela Ileana Ionescu, et al.
Published: (2018-05-01)

Meeting an un-MET need: Targeting MET in non-small cell lung cancer
by: Elena Michaels, et al.
Published: (2022-10-01)

Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors
by: Belma Zengin Kurt, et al.
Published: (2017-01-01)

Development of Novel Indole and Coumarin Derivatives as Antibacterial Agents That Target Histidine Kinase in <i>S. aureus</i>
by: Lisha K. Poonacha, et al.
Published: (2023-10-01)

Identification of the Kinase-Substrate Recognition Interface between MYPT1 and Rho-Kinase
by: Mutsuki Amano, et al.
Published: (2022-01-01)

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020-10-01)

MET in glioma: signaling pathways and targeted therapies
by: Fangling Cheng, et al.
Published: (2019-06-01)

Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents
by: Lamya H. Al-Wahaibi, et al.
Published: (2023-07-01)

Design, synthesis, and antitumor efficacy of novel 5-deazaflavin derivatives backed by kinase screening, docking, and ADME studies
by: Walaa A. Bedewy, et al.
Published: (2023-12-01)

Effect of propolis on pyruvate kinase and superoxide dismutase activities in doxorubicin–induced tissue damage: Molecular docking analysis
by: Seval Yilmaz, et al.
Published: (2024-02-01)

Developing a Kinase-Specific Target Selection Method Using a Structure-Based Machine Learning Approach
by: Afanasyeva A, et al.
Published: (2020-12-01)

Cobdock: an accurate and practical machine learning-based consensus blind docking method
by: Sadettin Y. Ugurlu, et al.
Published: (2024-01-01)

Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors
by: Maria Olivero-Acosta, et al.
Published: (2017-02-01)

7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-ones Designed by a “Cut and Glue” Strategy Are Dual Aurora A/VEGF-R Kinase Inhibitors
by: Mehmet Karatas, et al.
Published: (2021-03-01)

Discovery of Kinase and Carbonic Anhydrase Dual Inhibitors by Machine Learning Classification and Experiments
by: Min-Jeong Kim, et al.
Published: (2022-02-01)

AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma
by: Federica Zito Marino, et al.
Published: (2022-12-01)

Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
by: Yumiko Tahira, et al.
Published: (2021-08-01)

Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
by: Amany Belal, et al.
Published: (2022-08-01)